CNBC, Berkeley Lovelace Jr., Dec. 10, 2020 A key Food and Drug Administration advisory panel voted 17 to 4 with one member abstaining on Thursday to recommend the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use, the last step before the FDA …